בוקולאם 7.5 מ"ג

Држава: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

MIDAZOLAM AS HYDROCHLORIDE 7.5 MG

Доступно од:

NEOPHARM CURE (2005) LTD

АТЦ код:

N05CD08

Фармацеутски облик:

OROMUCOSAL SOLUTION

Пут администрације:

BUCCAL

Произведен од:

SCM PHARMA LIMITED, UK

Терапеутска група:

MIDAZOLAM

Терапеутске индикације:

Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Датум одобрења:

2013-05-01